TLR7/8 agonist 3
CAS No. 642473-95-8
TLR7/8 agonist 3( —— )
Catalog No. M26483 CAS No. 642473-95-8
TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 262 | Get Quote |
|
| 10MG | 434 | Get Quote |
|
| 25MG | 710 | Get Quote |
|
| 50MG | 972 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTLR7/8 agonist 3
-
NoteResearch use only, not for human use.
-
Brief DescriptionTLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
-
DescriptionTLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorSMARCA2| SMARCA4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number642473-95-8
-
Formula Weight313.405
-
Molecular FormulaC17H23N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (159.54 mM)
-
SMILESCCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Loxoribine
Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.
-
BBIQ
BBIQ is a powerful vaccine adjuvant that enhances innate immune responses and it is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 (TLR7) agonist with an EC50 of 59.1 nM for human TLR7.
-
BMS-905
BMS-905 is a potent dual inhibitors of TLR7 and TLR8 with good selectivity against TLR9 and other family members. BMS-905 can be used in studies about the treatment of diseases such as psoriasis, arthritis, and lupus.
Cart
sales@molnova.com